Pricing Log in Create free account

Aligos Therapeutics, Inc. (ALGS) vs Edesa Biotech, Inc. (EDSA)

Aligos Therapeutics, Inc. and Edesa Biotech, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and Edesa Biotech, Inc. are of similar size ($28.8M and $28.2M). Aligos Therapeutics, Inc. grew revenue faster over the last twelve months: 1,171.6% against −43.5%. Edesa Biotech, Inc. has the higher net margin (0.00% vs −197.0%) and the higher return on invested capital (0.00% vs −400.9%). Across the 16 metrics below, Aligos Therapeutics, Inc. leads on 9 and Edesa Biotech, Inc. on 7.

Valuation

Metric ALGS EDSA Biotechnology median
P/E n/m n/m 10.60
P/S 1.27 59.44 9.40
P/B 3.78 48.99 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.37 28.02 9.02
Earnings yield (155.26%) (77.88%) (32.88%)
Free cash flow yield (160.62%) (45.60%) (23.13%)

Profitability

Metric ALGS EDSA Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (215.55%) 0.00% 0.00%
Net margin (197.01%) 0.00% 0.00%
Free cash flow margin (203.21%) 0.00% 0.00%
Return on equity (159.46%) (531.32%) (51.96%)
Return on assets (84.46%) (102.46%) (46.06%)
Return on invested capital (400.91%) 0.00% 0.00%

Growth

Metric ALGS EDSA Biotechnology median
Revenue growth (TTM) 1,171.58% (43.48%) 6.76%
EPS growth (last fiscal year) 88.30% 34.20% 29.88%
Revenue growth, 5-year CAGR — (15.40%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALGS EDSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.77 2.76 4.97
Net debt to EBITDA 0.87 1.39 1.01

Dividend

Metric ALGS EDSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALGS EDSA Biotechnology median
Market cap 28.17m 28.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack